Drug Shortage Report for SANDOZ SAXAGLIPTIN

Last updated on 2021-07-26 History
Report ID 141299
Drug Identification Number 02468611
Brand name SANDOZ SAXAGLIPTIN
Common or Proper name SANDOZ SAXAGLIPTIN
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) SAXAGLIPTIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30FCT CA
ATC code A10BH
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-06-18
Estimated end date 2021-07-16
Actual end date 2021-07-16
Shortage status Resolved
Updated date 2021-07-26
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-07-26 French Compare
v3 2021-07-26 English Compare
v2 2021-06-21 French Compare
v1 2021-06-21 English Compare

Showing 1 to 4 of 4